The Vanguard Group Discloses Position in Mural Oncology

The Vanguard Group, Inc. has disclosed its position in Mural Oncology plc through a Form 8.3 submitted under Rule 8.3 of the Irish Takeover Panel Act, 1997. As of November 18, 2025, Vanguard holds 1.67% interest in Mural Oncology, encompassing 288,859 ordinary shares priced at $0.01 each. No short positions or derivative transactions were noted in the disclosure.

Vanguard's filing did not involve engagements in any indemnity or related agreements concerning Mural's securities. The disclosure indicates no involvement in stock-settled derivatives, with only a minor transaction of 16 ordinary shares purchased at 2.10 USD per unit. No supplemental forms accompanied the filing.